Bausch + Lomb Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bausch + Lomb Corp.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
/ 
Frequently asked questions
To buy Bausch + Lomb Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bausch + Lomb Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bausch + Lomb Corp. is BLCO:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bausch + Lomb Corp. has its primary listing on New York Stock Exchange. You can trade Bausch + Lomb Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bausch + Lomb Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bausch + Lomb Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bausch + Lomb Corp..